Global Health Investment Corporation reposted this
Excited to continue working with Rachel Sha and the rest of the team at Vaxess Technologies, which today announced a $12m financing to support the development of patch-based drugs and vaccines. RA Capital Management Mario Barro Engine Ventures Ann DeWitt Fenel M. Eloi Mission BioCapital Johannes Fruehauf
Today, Vaxess is announcing $12M in additional funding for its industry-leading skin patch for drug delivery. We’re honored to be backed by an extraordinary team of investors in the vaccine and therapeutic space, including RA Capital Management, Engine Ventures, Global Health Investment Corporation, and Mission BioCapital. After a year where Vaxess has demonstrated feasibility of GLP-1 delivery, and partnered with leading biopharma companies in vaccines (mRNA and non-mRNA), Vaxess will focus on applying the MIMIX skin patch to a range of therapeutics and vaccines. With this additional funding, Vaxess is also announcing that Michael Schrader is stepping down as the company’s CEO, and Rachel Sha is joining the company as CEO. https://lnkd.in/e-UN-Hki